Manuel
Cuenca Estrella
Publicaciones en las que colabora con Manuel Cuenca Estrella (38)
2024
2022
-
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis
Mycoses, Vol. 65, Núm. 12, pp. 1073-1111
-
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data
Journal of Infection
2021
-
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection
Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761
2020
-
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis
Journal of Infection, Vol. 81, Núm. 1, pp. 131-146
-
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
The Lancet, Vol. 396, Núm. 10250, pp. 535-544
-
Roles of the multiplex real-time PCR assay and β-D-glucan in a high-risk population for intra-abdominal candidiasis (IAC)
Medical mycology, Vol. 58, Núm. 6, pp. 789-796
2019
-
Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome
Transplant Infectious Disease, Vol. 21, Núm. 6
-
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project
Mycoses, Vol. 62, Núm. 4, pp. 310-319
-
Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 8, pp. 535-541
2018
-
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection, Vol. 24, pp. e1-e38
-
Endemic fungal infection recommendations for solid-organ transplant recipients and donors
Transplantation, Vol. 102, Núm. 2S, pp. S52-S59
2017
-
Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7
-
Epidemiology and prognosis of candidaemia in elderly patients
Mycoses, Vol. 60, Núm. 12, pp. 808-817
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
-
Performance of a quantitative pcrbased assay and beta-D-glucan detection for diagnosis of invasive candidiasis in very-low-birth-weight preterm neonatal patients (candineo study)
Journal of Clinical Microbiology, Vol. 55, Núm. 9, pp. 2752-2764
2016
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394